KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) EPS (Weighted Average and Diluted) (2020 - 2025)

Historic EPS (Weighted Average and Diluted) for Vir Biotechnology (VIR) over the last 6 years, with Q3 2025 value amounting to -$1.17.

  • Vir Biotechnology's EPS (Weighted Average and Diluted) rose 2500.0% to -$1.17 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.61, marking a year-over-year increase of 790.82%. This contributed to the annual value of -$3.83 for FY2024, which is 1653.62% up from last year.
  • Latest data reveals that Vir Biotechnology reported EPS (Weighted Average and Diluted) of -$1.17 as of Q3 2025, which was up 2500.0% from -$0.8 recorded in Q2 2025.
  • Over the past 5 years, Vir Biotechnology's EPS (Weighted Average and Diluted) peaked at $3.94 during Q4 2021, and registered a low of -$1.56 during Q3 2024.
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$0.19, with a median of -$0.8 in 2025.
  • Per our database at Business Quant, Vir Biotechnology's EPS (Weighted Average and Diluted) surged by 56352.94% in 2021 and then crashed by 22608.7% in 2022.
  • Quarter analysis of 5 years shows Vir Biotechnology's EPS (Weighted Average and Diluted) stood at $3.94 in 2021, then tumbled by 119.04% to -$0.75 in 2022, then decreased by 14.67% to -$0.86 in 2023, then grew by 10.74% to -$0.77 in 2024, then tumbled by 52.41% to -$1.17 in 2025.
  • Its last three reported values are -$1.17 in Q3 2025, -$0.8 for Q2 2025, and -$0.88 during Q1 2025.